A time-resolved proteomic and prognostic map of COVID-19Vadim Demichev, Judith Löffler‐Ragg, Elisa T. Helbig et al.|Cell Systems|2021Cited by 222
A proteomic survival predictor for COVID-19 patients in intensive careVadim Demichev, Caroline Hayward, Pinkus Tober‐Lau et al.|PLOS Digital Health|2022Cited by 69
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational studyCharlotte Thibeault, Yaosi Li, Barbara Mühlemann et al.|Infection|2021Cited by 31
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patientsSilke Leonhardt, Uwe D. Behrens, Christian Jürgensen et al.|Hepatology International|2023Cited by 23
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational studyBarbara Mühlemann, Philipp Knape, Charlotte Thibeault et al.|Clinical Microbiology and Infection|2021Cited by 18